Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.61 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | FDPS | P14324 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL718008 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL717168 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL87652 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL28984795 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL10871818 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL28462437 | 0.98 | CYP4F2 (0.59) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL503887 | 0.94 | CYP4F2 (0.56) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| Acetic Acid SCHEMBL8601641 | 0.94 | MEN1 (0.58) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL6531912 | 0.94 | CYP4F2 (0.56) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL369993 | 0.94 | CYP4F2 (0.56) | CYP4F2CYP4A11MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 920 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113660932-B | Phenyl derivatives having pendant alkyl and alkenyl extensions and pharmaceutical compositions comprising the same | 景凯生物科技股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-118265453-A | Protein aggregation inhibiting compounds for plant disease control | 马克斯·普朗克科学促进学会 | 2024-06-28 | — | — | CN | disclosed |
| CN-115515956-B | Benzimidazole derivative, and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-115461334-B | Benzimidazole derivative, and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-4384013-A1 | PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2024-06-19 | — | — | EP | disclosed |
| CN-112437773-B | Catechol derivatives or salts thereof, process for preparing the same and pharmaceutical compositions containing the same | 六合医药科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-118126046-A | Substituted macrocyclic compound, and preparation method and application thereof | 深圳信立泰药业股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| US-20240166627-A1 | Terpyridinedione compound or salt thereof, and preparation method and application thereof | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) | 2024-05-23 | — | — | US | disclosed |
| CN-115515938-B | Salts of FXIa inhibitor compounds, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117919443-A | Covalent organic framework combining diagnosis of hypoxia-activated therapy and self-accelerating drug release to coordinate cancer immunotherapy | 长春工业大学 | 2024-04-26 | — | — | CN | disclosed |
| EP-0443513-A2 | Azoxy compounds | KOWA COMPANY, LTD. (JP) | 1991-08-28 | — | — | EP | disclosed |
| US-4990531-A | Antispasmodic agents | ROUSSEL UCLAF (FR) | 1991-02-05 | — | — | US | disclosed |
| EP-0382884-A1 | Oxazolidinedione compounds, the process for preparing the same and herbicidal composition containing the same | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1990-08-22 | — | — | EP | disclosed |
| US-4948804-A | TREATING PSYCHOLOGICAL DISORDERS | ROUSSEL UCLAF (FR) | 1990-08-14 | — | — | US | disclosed |
| EP-0347902-A2 | Pyrrolecarboxylic acid derivatives | Mitsubishi Chemical Corporation (JP) | 1989-12-27 | — | — | EP | disclosed |
| EP-0346465-A1 | 1-CARBOXY-1-VYNILOXYIMINOAMINOTHIAZOLE CEPHALOSPORING DERIVATIVES AND PROCESS FOR THEIR PREPARATION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-12-20 | — | — | EP | disclosed |
| US-4886903-A | Process for production of prostaglandins D2 | TEIJIN LIMITED (JP) | 1989-12-12 | — | — | US | disclosed |
| US-4705554-A | Benzofuranyloxyphenylurea derivative and herbicidal composition containing it as an active ingredient | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1987-11-10 | — | — | US | disclosed |
| EP-0224816-A1 | Benzofuranyloxyphenylurea derivative and herbicidal composition containing it as an active ingredient | MITSUBISHI KASEI CORPORATION (JP) | 1987-06-10 | — | — | EP | disclosed |
| EP-0157637-A2 | Heterocyclic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1985-10-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166627-A1 | Terpyridinedione compound or salt thereof, and preparation method and application thereof | TNF, MAPKAPK2, MAPK1 | CYP4F2 536/4885CYP4A11 378/4885MEN1 2760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.